Free Trial

Hims & Hers Health (HIMS) News Today

Hims & Hers Health logo
$49.94 +0.53 (+1.07%)
As of 03:58 PM Eastern

Why is Hims & Hers Health Up Today?

Hims & Hers Health, Inc. (NYSE: HIMS) shares have been pressured by a wave of securities‐fraud class action filings and the loss of a key partnership, even as analysts weigh the telehealth company’s growth prospects.

  • Bullish Commentary: The Motley Fool’s “Great News for Hims & Hers Stock Investors” article hints at catalysts that could spur a recovery after the late‐June sell-off.
  • Analyst Comparison: Zacks highlights HIMS’ stronger earnings growth and expansion momentum relative to LifeMD, pointing to potential upside.
  • Trading Volume Spike: American Banking News reports unusually high volume in HIMS shares, signaling elevated investor attention and possible volatility.
  • MarketBeat Analysis: Notes a ~1.1% dip in trading and asks whether it’s “Time to Sell?”, reflecting short-term uncertainty.
  • Partnership Cancellation: Novo Nordisk terminated its Wegovy® collaboration after alleging “deceptive” marketing, undercutting HIMS’ weight-loss ambitions.
  • Class Action Suits: Multiple firms (Bronstein Gewirtz & Grossman; Kessler Topaz Meltzer & Check; Hagens Berman; Bernstein Liebhard; Bleichmar Fonti & Auld; Robbins Geller Rudman & Dowd; Rosen Law) have filed or alerted investors to lawsuits alleging federal securities-law violations for purchases made between April 29 and June 23, 2025.
Posted 1h agoAI Generated. May Contain Errors.

HIMS Latest News

Great News for Hims & Hers Stock Investors
Top Medical Stocks To Watch Now - June 27th
Hims & Hers Health (NYSE:HIMS) Shares Up 7% - Still a Buy?
Massive News for Hims & Hers Stock Investors!
Get Hims & Hers Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter.

Related Videos

4 Biotech Stocks on the Verge of Massive Breakthroughs

HIMS Media Mentions By Week

HIMS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HIMS
News Sentiment

0.10

0.90

Average
Medical
News Sentiment

HIMS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HIMS Articles
This Week

112

25

HIMS Articles
Average Week

Get Hims & Hers Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:HIMS) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners